Medical Imaging Equipment Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

Description

Persistence Market Research has recently published an in-depth report on the global medical imaging equipment market, offering detailed insights into market dynamics, including drivers, trends, opportunities, and challenges. This report aims to provide a comprehensive understanding of the market structure and future outlook, particularly for stakeholders in the healthcare and medical device industries.

Key Insights:

Global Market Revenue (2022): US$ 42.7 Billion
Estimated Market Value (2033): US$ 64.8 Billion
Global Market Growth Rate (CAGR 2022-2033): 4.7%

Global Medical Imaging Equipment Market - Report Scope:

The medical imaging equipment market covers a broad range of devices used in the diagnosis and monitoring of various diseases and conditions. These include X-ray machines, MRI systems, ultrasound devices, and CT scanners. The market is driven by the need for early and accurate diagnosis, particularly for conditions like tuberculosis, cardiovascular diseases, and orthopedic disorders.

Market Growth Drivers:

Growing Incidences of Tuberculosis (TB)

Tuberculosis (TB) remains one of the leading infectious diseases globally, with significant demand for medical imaging equipment, particularly in low- and middle-income countries. According to the World Health Organization (WHO), around 10 million people develop TB annually, with the disease claiming approximately 1.5 million lives each year. The majority of TB cases are concentrated in eight countries, including Bangladesh, China, Pakistan, the Philippines, Indonesia, India, Nigeria, and South Africa. The rising prevalence of TB in these regions is driving the demand for X-ray and MRI equipment, which are crucial for diagnosing and monitoring the disease.

Rising Geriatric Population

The global geriatric population is increasing at a rapid pace, particularly in emerging markets. According to WHO estimates, there were over 1 billion people aged 60 and above in 2019, with this number expected to reach 1.4 billion by 2030 and 2 billion by 2050. The aging population is more susceptible to a range of health issues, including respiratory diseases (such as tuberculosis and pneumonia), orthopedic conditions (like osteoporosis), and cardiovascular diseases. The need for early and accurate diagnosis of these conditions is driving demand for medical imaging equipment. Technologies such as X-ray, ultrasound, MRI, and CT are essential for diagnosing and managing these age-related health issues.

Adoption of AI in Data Management

The integration of artificial intelligence (AI) into medical imaging is revolutionizing the industry. AI-driven tools are enhancing the accuracy and efficiency of imaging processes, enabling better diagnosis and treatment planning. The adoption of AI in data management within the medical imaging sector is expected to drive market growth, as it allows for more precise imaging, faster analysis, and improved patient outcomes.

Industry Collaborations and Innovations

The medical imaging equipment market is also benefiting from industry-wide collaborations and innovations. For instance, in January 2022, O2 Investment Partners collaborated with Modular Devices, Inc. to support the company's growth and provide advanced imaging modalities. Such partnerships are expected to drive further advancements in medical imaging technology, making it more accessible and effective.

Market Challenges:

High Costs and Infrastructure Requirements

One of the significant challenges facing the medical imaging equipment market is the high cost of devices and the infrastructure needed to support them. Advanced imaging technologies such as MRI and CT scanners require substantial investment, which can be a barrier in low- and middle-income countries. Additionally, the maintenance and operation of these devices require specialized skills and facilities, which may not be readily available in all regions.

Regulatory and Compliance Issues

The medical imaging sector is subject to strict regulatory standards to ensure patient safety and device efficacy. Navigating these regulations can be complex and time-consuming, particularly for companies looking to introduce new technologies or expand into new markets. Compliance with these regulations is essential, but it can also slow down the adoption of new technologies and impact market growth.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the global medical imaging equipment market?
Which consumer segments are leading the adoption of advanced imaging technologies?
How are technological advancements and AI integration influencing the competitive landscape?
Who are the key players in the global medical imaging equipment market, and what strategies are they employing to maintain their market position?
What are the emerging trends and future prospects in the global medical imaging equipment market?

Competitive Intelligence and Business Strategy:

Leading players in the global medical imaging equipment market, such as Siemens Healthineers, GE Healthcare, and Philips Healthcare, are focusing on product innovation, strategic collaborations, and expanding their presence in emerging markets. These companies are investing heavily in research and development to create advanced imaging technologies that offer enhanced diagnostic capabilities and better patient outcomes. Partnerships and collaborations are also playing a key role in driving innovation and expanding the reach of these technologies globally.

Key Companies Profiled:

GE Healthcare
Hitachi Medical Corporation
Philips Healthcare
Siemens Healthineers
Toshiba Medical Systems Corporation
Esaote S.p.A
Positron Corporation
Neusoft Medical Systems
Neurologica Corporation
Mediso Medical Imaging Systems
Digirad
SHIMADZU CORPORATION
Hologic, Inc.
Guerbet SA
Bayer AG
Mallinckrodt
Bracco Imaging S.p.A
Ulrich GmbH & Co. KG
Medtron
Nemoto Kyorindo Co. Ltd
Lemer Pax

Key Segments Covered in Medical Imaging Equipment Industry Research

Equipment:

Computed Tomography (CT) Systems
X-ray Systems
MRI Systems
Ultrasound Systems
Nuclear Imaging Equipment
Mammography Equipment
Contrast Media Injectors
C-Arms & Fluoroscopy Devices

Modality:

Stand-Alone Devices
Portable Devices
Hand-Held Devices

End User:

Diagnostic Imaging Centers
Ambulatory Surgical Centers
Specialty Clinics
Research Institutes

Region:

North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East and Africa (MEA)

Product Code: PMRREP11215

1. Executive Summary

1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Technology Roadmap
1.5. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Product Adoption Analysis
4.2. Product USPs/ Features
4.3. Regulatory Landscape
4.4. Install Base Scenario
4.5. Recent Product Approved
4.6. Product Recall
4.7. Technology Assessment
4.8. Value Chain Analysis
4.9. PESTLE Analysis
4.10. Porter's Analysis

5. Market Background

5.1. Macro-Economic Factors
- 5.1.1. Global GDP Growth Outlook
- 5.1.2. Global Healthcare Outlook
- 5.1.3. Global Medical Devices Market Outlook
5.2. Forecast Factors - Relevance & Impact
- 5.2.1. Rising incidence of chronic diseases
- 5.2.2. Rising Demand in Emerging Economies for Imaging Technologies
- 5.2.3. Growing Advancements in Maneuverability and Imaging Capabilities
- 5.2.4. Adoption of alternative techniques
- 5.2.5. Strategic mergers and acquisitions
- 5.2.6. Favorable Reimbursement scenario
5.3. Market Dynamics
- 5.3.1. Drivers
- 5.3.2. Restraints
- 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

6.1. COVID-19 and Impact Analysis
- 6.1.1. By Equipment
- 6.1.2. By Modality
- 6.1.3. By End User
- 6.1.4. By Region
6.2. 2024 Market Scenario

7. Global Market Volume (in Units) Analysis 2019-2023 and Forecast, 2024-2033

7.1. Historical Volume (in Units) Analysis, 2019-2023
7.2. Current and Future Volume (in Units) Projections, 2024-2033
- 7.2.1. Y-o-Y Growth Trend Analysis
- 7.2.2. Absolute $ Opportunity Analysis

8. Global Market - Pricing Analysis

8.1. Regional Pricing Analysis By Product
8.2. Pricing Break-up
- 8.2.1. Manufacturer Level Pricing
- 8.2.2. Distributor Level Pricing
8.3. Global Average Pricing Analysis Benchmark
8.4. Pricing Assumptions

9. Global Market Demand (in Value US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033

9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Analysis and Forecast, 2024-2033
- 9.2.1. Y-o-Y Growth Trend Analysis
- 9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Equipment

10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Equipment, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Equipment, 2024-2033
- 10.3.1. Computed Tomography (CT) Systems
  - 10.3.1.1. 256-320 slice CT Systems
  - 10.3.1.2. 128-slice CT Systems
  - 10.3.1.3. 64-slice CT Systems
  - 10.3.1.4. 16-slice and below CT Systems
- 10.3.2. X-ray Systems
  - 10.3.2.1. Analog X-ray Systems
  - 10.3.2.2. Digital X-ray Systems
    - 10.3.2.2.1. Computed Radiography (CR) Systems
    - 10.3.2.2.2. Digital Radiography (DR) Systems
    - 10.3.2.2.3. Retrofit X-ray Systems
- 10.3.3. MRI Systems
  - 10.3.3.1. 0.7 T MRI Systems
  - 10.3.3.2. 1.5 T MRI Systems
  - 10.3.3.3. 3 T MRI Systems
  - 10.3.3.4. 7 T MRI Systems
  - 10.3.3.5. Others
- 10.3.4. Ultrasound Systems
  - 10.3.4.1. Black & White Ultrasound Systems
  - 10.3.4.2. Color Doppler Ultrasound Systems
- 10.3.5. Nuclear Imaging Equipment
  - 10.3.5.1. Positron Emission Tomography (PET) Systems
    - 10.3.5.1.1. PET Scanners
    - 10.3.5.1.2. PET/CT
    - 10.3.5.1.3. PET/MRI
  - 10.3.5.2. Single-Photon Emission Computed Tomography
    - 10.3.5.2.1. Single Imaging Gamma Cameras
    - 10.3.5.2.2. SPECT/CT
- 10.3.6. Mammography Equipment
  - 10.3.6.1. Film-Screen Mammography Equipment
  - 10.3.6.2. 2D Digital Mammography Equipment
  - 10.3.6.3. 3D Tomosynthesis
- 10.3.7. Contrast Media Injectors
  - 10.3.7.1. CT Injectors
  - 10.3.7.2. MRI Injectors
  - 10.3.7.3. Cardio Injectors
  - 10.3.7.4. PET Injectors
- 10.3.8. C-Arms & Fluoroscopy Devices
  - 10.3.8.1. C-Arms Systems
    - 10.3.8.1.1. Full Size C - arms Systems
    - 10.3.8.1.2. Mini C - arms Systems
  - 10.3.8.2. Fluoroscopy Devices
10.4. Market Attractiveness Analysis, by Equipment

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Modality

11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By Modality, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by Modality, 2024-2033
- 11.3.1. Stand-Alone Devices
- 11.3.2. Portable Devices
- 11.3.3. Hand-Held Devices
11.4. Market Attractiveness Analysis, by Modality

12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast, by End User, 2024-2033
- 12.3.1. Diagnostic Imaging Centers
- 12.3.2. Ambulatory Surgical Centers
- 12.3.3. Specialty Clinics
- 12.3.4. Research Institutes
12.4. Market Attractiveness Analysis, by End User

13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Region, 2019-2023
13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 13.3.1. North America
- 13.3.2. Latin America
- 13.3.3. Europe
- 13.3.4. East Asia
- 13.3.5. South Asia
- 13.3.6. Oceania
- 13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis, by Region

14. North America Market Analysis 2019-2023 and Forecast 2024-2033

14.1. Introduction
14.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 14.3.1. By Country
  - 14.3.1.1. U.S.
  - 14.3.1.2. Canada
- 14.3.2. By Equipment
- 14.3.3. By Modality
- 14.3.4. By End User
14.4. Market Attractiveness Analysis
- 14.4.1. By Country
- 14.4.2. By Equipment
- 14.4.3. By Modality
- 14.4.4. By End User
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
- 14.7.1. U.S. Market Analysis
  - 14.7.1.1. Introduction
  - 14.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.1.2.1. By Equipment
    - 14.7.1.2.2. By Modality
    - 14.7.1.2.3. By End User
- 14.7.2. Canada Market Analysis
  - 14.7.2.1. Introduction
  - 14.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 14.7.2.2.1. By Equipment
    - 14.7.2.2.2. By Modality
    - 14.7.2.2.3. By End User

15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

15.1. Introduction
15.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 15.3.1. By Country
  - 15.3.1.1. Mexico
  - 15.3.1.2. Brazil
  - 15.3.1.3. Argentina
  - 15.3.1.4. Rest of Latin America
- 15.3.2. By Equipment
- 15.3.3. By Modality
- 15.3.4. By End User
15.4. Market Attractiveness Analysis
- 15.4.1. By Country
- 15.4.2. By Equipment
- 15.4.3. By Modality
- 15.4.4. By End User
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
- 15.7.1. Mexico Market Analysis
  - 15.7.1.1. Introduction
  - 15.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.1.2.1. By Equipment
    - 15.7.1.2.2. By Modality
    - 15.7.1.2.3. By End User
- 15.7.2. Brazil Market Analysis
  - 15.7.2.1. Introduction
  - 15.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.2.2.1. By Equipment
    - 15.7.2.2.2. By Modality
    - 15.7.2.2.3. By End User
- 15.7.3. Argentina Market Analysis
  - 15.7.3.1. Introduction
  - 15.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 15.7.3.2.1. By Equipment
    - 15.7.3.2.2. By Modality
    - 15.7.3.2.3. By End User

16. Europe Market Analysis 2019-2023 and Forecast 2024-2033

16.1. Introduction
16.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 16.3.1. By Country
  - 16.3.1.1. Germany
  - 16.3.1.2. Italy
  - 16.3.1.3. France
  - 16.3.1.4. U.K.
  - 16.3.1.5. Spain
  - 16.3.1.6. Russia
  - 16.3.1.7. BENELUX
  - 16.3.1.8. Rest of Europe
- 16.3.2. By Equipment
- 16.3.3. By Modality
- 16.3.4. By End User
16.4. Market Attractiveness Analysis
- 16.4.1. By Country
- 16.4.2. By Equipment
- 16.4.3. By Modality
- 16.4.4. By End User
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Country Level Analysis & Forecast
- 16.7.1. Germany Market Analysis
  - 16.7.1.1. Introduction
  - 16.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.1.2.1. By Equipment
    - 16.7.1.2.2. By Modality
    - 16.7.1.2.3. By End User
- 16.7.2. Italy Market Analysis
  - 16.7.2.1. Introduction
  - 16.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.2.2.1. By Equipment
    - 16.7.2.2.2. By Modality
    - 16.7.2.2.3. By End User
- 16.7.3. France Market Analysis
  - 16.7.3.1. Introduction
  - 16.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.3.2.1. By Equipment
    - 16.7.3.2.2. By Modality
    - 16.7.3.2.3. By End User
- 16.7.4. U.K. Market Analysis
  - 16.7.4.1. Introduction
  - 16.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.4.2.1. By Equipment
    - 16.7.4.2.2. By Modality
    - 16.7.4.2.3. By End User
- 16.7.5. Spain Market Analysis
  - 16.7.5.1. Introduction
  - 16.7.5.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.5.2.1. By Equipment
    - 16.7.5.2.2. By Modality
    - 16.7.5.2.3. By End User
- 16.7.6. Russia Market Analysis
  - 16.7.6.1. Introduction
  - 16.7.6.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.6.2.1. By Equipment
    - 16.7.6.2.2. By Modality
    - 16.7.6.2.3. By End User
- 16.7.7. BENELUX Market Analysis
  - 16.7.7.1. Introduction
  - 16.7.7.2. Market Analysis and Forecast, by Market Taxonomy
    - 16.7.7.2.1. By Equipment
    - 16.7.7.2.2. By Modality
    - 16.7.7.2.3. By End User

17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

17.1. Introduction
17.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 17.3.1. By Country
  - 17.3.1.1. China
  - 17.3.1.2. Japan
  - 17.3.1.3. South Korea
- 17.3.2. By Equipment
- 17.3.3. By Modality
- 17.3.4. By End User
17.4. Market Attractiveness Analysis
- 17.4.1. By Equipment
- 17.4.2. By Modality
- 17.4.3. By End User
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Country Level Analysis & Forecast
- 17.7.1. China Market Analysis
  - 17.7.1.1. Introduction
  - 17.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.7.1.2.1. By Equipment
    - 17.7.1.2.2. By Modality
    - 17.7.1.2.3. By End User
- 17.7.2. Japan Market Analysis
  - 17.7.2.1. Introduction
  - 17.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.7.2.2.1. By Equipment
    - 17.7.2.2.2. By Modality
    - 17.7.2.2.3. By End User
- 17.7.3. South Korea Market Analysis
  - 17.7.3.1. Introduction
  - 17.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 17.7.3.2.1. By Equipment
    - 17.7.3.2.2. By Modality
    - 17.7.3.2.3. By End User

18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033

18.1. Introduction
18.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 18.3.1. By Country
  - 18.3.1.1. India
  - 18.3.1.2. Indonesia
  - 18.3.1.3. Malaysia
  - 18.3.1.4. Thailand
  - 18.3.1.5. Rest of South Asia
- 18.3.2. By Equipment
- 18.3.3. By Modality
- 18.3.4. By End User
18.4. Market Attractiveness Analysis
- 18.4.1. By Country
- 18.4.2. By Equipment
- 18.4.3. By Modality
- 18.4.4. By End User
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Country Level Analysis & Forecast
- 18.7.1. India Market Analysis
  - 18.7.1.1. Introduction
  - 18.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.1.2.1. By Equipment
    - 18.7.1.2.2. By Modality
    - 18.7.1.2.3. By End User
- 18.7.2. Indonesia Market Analysis
  - 18.7.2.1. Introduction
  - 18.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.2.2.1. By Equipment
    - 18.7.2.2.2. By Modality
    - 18.7.2.2.3. By End User
- 18.7.3. Malaysia Market Analysis
  - 18.7.3.1. Introduction
  - 18.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.3.2.1. By Equipment
    - 18.7.3.2.2. By Modality
    - 18.7.3.2.3. By End User
- 18.7.4. Thailand Market Analysis
  - 18.7.4.1. Introduction
  - 18.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 18.7.4.2.1. By Equipment
    - 18.7.4.2.2. By Modality
    - 18.7.4.2.3. By End User

19. Oceania Market 2019-2023 and Forecast 2024-2033

19.1. Introduction
19.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 19.3.1. By Country
  - 19.3.1.1. Australia
  - 19.3.1.2. New Zealand
- 19.3.2. By Equipment
- 19.3.3. By Modality
- 19.3.4. By End User
19.4. Market Attractiveness Analysis
- 19.4.1. By Country
- 19.4.2. By Equipment
- 19.4.3. By Modality
- 19.4.4. By End User
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Country Level Analysis & Forecast
- 19.7.1. Australia Market Analysis
  - 19.7.1.1. Introduction
  - 19.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 19.7.1.2.1. By Equipment
    - 19.7.1.2.2. By Modality
    - 19.7.1.2.3. By End User
- 19.7.2. New Zealand Market Analysis
  - 19.7.2.1. Introduction
  - 19.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 19.7.2.2.1. By Equipment
    - 19.7.2.2.2. By Modality
    - 19.7.2.2.3. By End User

20. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

20.1. Introduction
20.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, by Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
- 20.3.1. By Country
  - 20.3.1.1. GCC Countries
  - 20.3.1.2. Turkiye
  - 20.3.1.3. South Africa
  - 20.3.1.4. North Africa
  - 20.3.1.5. Rest of Middle East and Africa
- 20.3.2. By Equipment
- 20.3.3. By Modality
- 20.3.4. By End User
20.4. Market Attractiveness Analysis
- 20.4.1. By Equipment
- 20.4.2. By Modality
- 20.4.3. By End User
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Country Level Analysis & Forecast
- 20.7.1. GCC Countries Market Analysis
  - 20.7.1.1. Introduction
  - 20.7.1.2. Market Analysis and Forecast, by Market Taxonomy
    - 20.7.1.2.1. By Equipment
    - 20.7.1.2.2. By Modality
    - 20.7.1.2.3. By End User
- 20.7.2. Turkiye Market Analysis
  - 20.7.2.1. Introduction
  - 20.7.2.2. Market Analysis and Forecast, by Market Taxonomy
    - 20.7.2.2.1. By Equipment
    - 20.7.2.2.2. By Modality
    - 20.7.2.2.3. By End User
- 20.7.3. South Africa Market Analysis
  - 20.7.3.1. Introduction
  - 20.7.3.2. Market Analysis and Forecast, by Market Taxonomy
    - 20.7.3.2.1. By Equipment
    - 20.7.3.2.2. By Modality
    - 20.7.3.2.3. By End User
- 20.7.4. North Africa Market Analysis
  - 20.7.4.1. Introduction
  - 20.7.4.2. Market Analysis and Forecast, by Market Taxonomy
    - 20.7.4.2.1. By Equipment
    - 20.7.4.2.2. By Modality
    - 20.7.4.2.3. By End User

21. Market Structure Analysis

21.1. Market Analysis, by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis

22. Competition Analysis

22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
- 22.3.1. GE Healthcare
  - 22.3.1.1. Overview
  - 22.3.1.2. Product Portfolio
  - 22.3.1.3. Sales Footprint
  - 22.3.1.4. Key Financials
  - 22.3.1.5. SWOT Analysis
  - 22.3.1.6. Strategy Overview
    - 22.3.1.6.1. Marketing Strategy
    - 22.3.1.6.2. Product Strategy
    - 22.3.1.6.3. Channel Strategy
- 22.3.2. Hitachi Medical Corporation
  - 22.3.2.1. Overview
  - 22.3.2.2. Product Portfolio
  - 22.3.2.3. Sales Footprint
  - 22.3.2.4. Key Financials
  - 22.3.2.5. SWOT Analysis
  - 22.3.2.6. Strategy Overview
    - 22.3.2.6.1. Marketing Strategy
    - 22.3.2.6.2. Product Strategy
    - 22.3.2.6.3. Channel Strategy
- 22.3.3. Philips Healthcare
  - 22.3.3.1. Overview
  - 22.3.3.2. Product Portfolio
  - 22.3.3.3. Sales Footprint
  - 22.3.3.4. Key Financials
  - 22.3.3.5. SWOT Analysis
  - 22.3.3.6. Strategy Overview
    - 22.3.3.6.1. Marketing Strategy
    - 22.3.3.6.2. Product Strategy
    - 22.3.3.6.3. Channel Strategy
- 22.3.4. Siemens Healthineers
  - 22.3.4.1. Overview
  - 22.3.4.2. Product Portfolio
  - 22.3.4.3. Sales Footprint
  - 22.3.4.4. Key Financials
  - 22.3.4.5. SWOT Analysis
  - 22.3.4.6. Strategy Overview
    - 22.3.4.6.1. Marketing Strategy
    - 22.3.4.6.2. Product Strategy
    - 22.3.4.6.3. Channel Strategy
- 22.3.5. Toshiba Medical Systems Corporation
  - 22.3.5.1. Overview
  - 22.3.5.2. Product Portfolio
  - 22.3.5.3. Sales Footprint
  - 22.3.5.4. Key Financials
  - 22.3.5.5. SWOT Analysis
  - 22.3.5.6. Strategy Overview
    - 22.3.5.6.1. Marketing Strategy
    - 22.3.5.6.2. Product Strategy
    - 22.3.5.6.3. Channel Strategy
- 22.3.6. Esaote S.p.A
  - 22.3.6.1. Overview
  - 22.3.6.2. Product Portfolio
  - 22.3.6.3. Sales Footprint
  - 22.3.6.4. Key Financials
  - 22.3.6.5. SWOT Analysis
  - 22.3.6.6. Strategy Overview
    - 22.3.6.6.1. Marketing Strategy
    - 22.3.6.6.2. Product Strategy
    - 22.3.6.6.3. Channel Strategy
- 22.3.7. Positron Corporation
  - 22.3.7.1. Overview
  - 22.3.7.2. Product Portfolio
  - 22.3.7.3. Sales Footprint
  - 22.3.7.4. Key Financials
  - 22.3.7.5. SWOT Analysis
  - 22.3.7.6. Strategy Overview
    - 22.3.7.6.1. Marketing Strategy
    - 22.3.7.6.2. Product Strategy
    - 22.3.7.6.3. Channel Strategy
- 22.3.8. Neusoft Medical Systems
  - 22.3.8.1. Overview
  - 22.3.8.2. Product Portfolio
  - 22.3.8.3. Sales Footprint
  - 22.3.8.4. Key Financials
  - 22.3.8.5. SWOT Analysis
  - 22.3.8.6. Strategy Overview
    - 22.3.8.6.1. Marketing Strategy
    - 22.3.8.6.2. Product Strategy
    - 22.3.8.6.3. Channel Strategy
- 22.3.9. Neurologica Corporation
  - 22.3.9.1. Overview
  - 22.3.9.2. Product Portfolio
  - 22.3.9.3. Sales Footprint
  - 22.3.9.4. Key Financials
  - 22.3.9.5. SWOT Analysis
  - 22.3.9.6. Strategy Overview
    - 22.3.9.6.1. Marketing Strategy
    - 22.3.9.6.2. Product Strategy
    - 22.3.9.6.3. Channel Strategy
- 22.3.10. Mediso Medical Imaging Systems
  - 22.3.10.1. Overview
  - 22.3.10.2. Product Portfolio
  - 22.3.10.3. Sales Footprint
  - 22.3.10.4. Key Financials
  - 22.3.10.5. SWOT Analysis
  - 22.3.10.6. Strategy Overview
    - 22.3.10.6.1. Marketing Strategy
    - 22.3.10.6.2. Product Strategy
    - 22.3.10.6.3. Channel Strategy
- 22.3.11. Digirad
  - 22.3.11.1. Overview
  - 22.3.11.2. Product Portfolio
  - 22.3.11.3. Sales Footprint
  - 22.3.11.4. Key Financials
  - 22.3.11.5. SWOT Analysis
  - 22.3.11.6. Strategy Overview
    - 22.3.11.6.1. Marketing Strategy
    - 22.3.11.6.2. Product Strategy
    - 22.3.11.6.3. Channel Strategy
- 22.3.12. SHIMADZU CORPORATION
  - 22.3.12.1. Overview
  - 22.3.12.2. Product Portfolio
  - 22.3.12.3. Sales Footprint
  - 22.3.12.4. Key Financials
  - 22.3.12.5. SWOT Analysis
  - 22.3.12.6. Strategy Overview
    - 22.3.12.6.1. Marketing Strategy
    - 22.3.12.6.2. Product Strategy
    - 22.3.12.6.3. Channel Strategy
- 22.3.13. Hologic, Inc.
  - 22.3.13.1. Overview
  - 22.3.13.2. Product Portfolio
  - 22.3.13.3. Sales Footprint
  - 22.3.13.4. Key Financials
  - 22.3.13.5. SWOT Analysis
  - 22.3.13.6. Strategy Overview
    - 22.3.13.6.1. Marketing Strategy
    - 22.3.13.6.2. Product Strategy
    - 22.3.13.6.3. Channel Strategy
- 22.3.14. Guerbet SA
  - 22.3.14.1. Overview
  - 22.3.14.2. Product Portfolio
  - 22.3.14.3. Sales Footprint
  - 22.3.14.4. Key Financials
  - 22.3.14.5. SWOT Analysis
  - 22.3.14.6. Strategy Overview
    - 22.3.14.6.1. Marketing Strategy
    - 22.3.14.6.2. Product Strategy
    - 22.3.14.6.3. Channel Strategy
- 22.3.15. Bayer AG
  - 22.3.15.1. Overview
  - 22.3.15.2. Product Portfolio
  - 22.3.15.3. Sales Footprint
  - 22.3.15.4. Key Financials
  - 22.3.15.5. SWOT Analysis
  - 22.3.15.6. Strategy Overview
    - 22.3.15.6.1. Marketing Strategy
    - 22.3.15.6.2. Product Strategy
    - 22.3.15.6.3. Channel Strategy
- 22.3.16. Mallinckrodt
  - 22.3.16.1. Overview
  - 22.3.16.2. Product Portfolio
  - 22.3.16.3. Sales Footprint
  - 22.3.16.4. Key Financials
  - 22.3.16.5. SWOT Analysis
  - 22.3.16.6. Strategy Overview
    - 22.3.16.6.1. Marketing Strategy
    - 22.3.16.6.2. Product Strategy
    - 22.3.16.6.3. Channel Strategy
- 22.3.17. Bracco Imaging S.p.A
  - 22.3.17.1. Overview
  - 22.3.17.2. Product Portfolio
  - 22.3.17.3. Sales Footprint
  - 22.3.17.4. Key Financials
  - 22.3.17.5. SWOT Analysis
  - 22.3.17.6. Strategy Overview
    - 22.3.17.6.1. Marketing Strategy
    - 22.3.17.6.2. Product Strategy
    - 22.3.17.6.3. Channel Strategy
- 22.3.18. Ulrich GmbH & Co. KG
  - 22.3.18.1. Overview
  - 22.3.18.2. Product Portfolio
  - 22.3.18.3. Sales Footprint
  - 22.3.18.4. Key Financials
  - 22.3.18.5. SWOT Analysis
  - 22.3.18.6. Strategy Overview
    - 22.3.18.6.1. Marketing Strategy
    - 22.3.18.6.2. Product Strategy
    - 22.3.18.6.3. Channel Strategy
- 22.3.19. Medtron
  - 22.3.19.1. Overview
  - 22.3.19.2. Product Portfolio
  - 22.3.19.3. Sales Footprint
  - 22.3.19.4. Key Financials
  - 22.3.19.5. SWOT Analysis
  - 22.3.19.6. Strategy Overview
    - 22.3.19.6.1. Marketing Strategy
    - 22.3.19.6.2. Product Strategy
    - 22.3.19.6.3. Channel Strategy
- 22.3.20. Nemoto Kyorindo Co. Ltd
  - 22.3.20.1. Overview
  - 22.3.20.2. Product Portfolio
  - 22.3.20.3. Sales Footprint
  - 22.3.20.4. Key Financials
  - 22.3.20.5. SWOT Analysis
  - 22.3.20.6. Strategy Overview
    - 22.3.20.6.1. Marketing Strategy
    - 22.3.20.6.2. Product Strategy
    - 22.3.20.6.3. Channel Strategy
- 22.3.21. Lemer Pax
  - 22.3.21.1. Overview
  - 22.3.21.2. Product Portfolio
  - 22.3.21.3. Sales Footprint
  - 22.3.21.4. Key Financials
  - 22.3.21.5. SWOT Analysis
  - 22.3.21.6. Strategy Overview
    - 22.3.21.6.1. Marketing Strategy
    - 22.3.21.6.2. Product Strategy
    - 22.3.21.6.3. Channel Strategy